Podcast
Empowered Patient Podcast
Hosted by Karen Jagoda · EN
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
148episodes
Episodes
Newest firstAll episodes
Using Longitudinal Sleep Data as a Vital Sign to Predict Disease Risk with Colin Lawlor Sleep ai TRANSCRIPT
4d agoTap to summarizeColin Lawlor, CEO of Sleep ai, is focused on exploring sleep intelligence and sleep as a vital sign of health. The Sleep ai platform measures sleep longitudinally using data from consumer wearables and smartphones, with an emphasis on night-to-night variability, which is not captured in a single-night sleep lab. Poor sleep and variation in sleep patterns have been identified as highly predictive indicators of over 130 chronic diseases and have an impact on mental well-being and the effectiveness of medical treatments. Colin explains, "What we're doing is we're measuring sleep longitudinally, over the long term, and we're measuring it from whatever device the consumer has. For some consumers or patients, it may be wearable, and there are many, many different wearables, or for others, it's simply from their phone. We have the ability to collect high-quality sleep data from everyone every day. And that's really important because when we get into this, we'll talk about why longitudinal measurement is really helpful in dealing with sleep challenges themselves, but also in seeing sleep as a window into literally everything to do with our health." "There are several factors going on here. The first one is that globally, four billion people wake up tired almost every day. We do not have, and we will never have, a sufficient number of sleep labs to send all of them for a one-night study. And if we collect data for only one night, we're only getting one picture of how that person is sleeping. But as we all know, life gets in the way. We may have had a stressful day, or we may have had an argument with our significant other. We may be suffering from a cold." "Whatever it is, all of these multiple factors influence sleep. So if we over-rely on one data point to understand what's going on, it's just not sufficient. So what we are finding is that, actually, the variance night to night is probably the most useful and insightful thing we can see. Because when we look at the variance across many nights, we have a much more accurate picture of what's happening with the person's sleep, and that's highly predictive of many, many other conditions, issues, and challenges." #SleepAI #DigitalHealth #SleepAsAVitalSign #ChronicDisease #PopulationHealth #AIinHealthcare #Wearables #LongitudinalData #SleepHealth, #SleepScience sleep.ai Listen to the podcast here
Transcribe →Using Longitudinal Sleep Data as a Vital Sign to Predict Disease Risk with Colin Lawlor Sleep ai
4d ago00:21:31Tap to summarizeColin Lawlor, CEO of Sleep ai, is focused on exploring sleep intelligence and sleep as a vital sign of health. The Sleep ai platform measures sleep longitudinally using data from consumer wearables and smartphones, with an emphasis on night-to-night variability, which is not captured in a single-night sleep lab. Poor sleep and variation in sleep patterns have been identified as highly predictive indicators of over 130 chronic diseases and have an impact on mental well-being and the effectiveness of medical treatments. Colin explains, "What we're doing is we're measuring sleep longitudinally, over the long term, and we're measuring it from whatever device the consumer has. For some consumers or patients, it may be wearable, and there are many, many different wearables, or for others, it's simply from their phone. We have the ability to collect high-quality sleep data from everyone every day. And that's really important because when we get into this, we'll talk about why longitudinal measurement is really helpful in dealing with sleep challenges themselves, but also in seeing sleep as a window into literally everything to do with our health." "There are several factors going on here. The first one is that globally, four billion people wake up tired almost every day. We do not have, and we will never have, a sufficient number of sleep labs to send all of them for a one-night study. And if we collect data for only one night, we're only getting one picture of how that person is sleeping. But as we all know, life gets in the way. We may have had a stressful day, or we may have had an argument with our significant other. We may be suffering from a cold." "Whatever it is, all of these multiple factors influence sleep. So if we over-rely on one data point to understand what's going on, it's just not sufficient. So what we are finding is that, actually, the variance night to night is probably the most useful and insightful thing we can see. Because when we look at the variance across many nights, we have a much more accurate picture of what's happening with the person's sleep, and that's highly predictive of many, many other conditions, issues, and challenges." #SleepAI #DigitalHealth #SleepAsAVitalSign #ChronicDisease #PopulationHealth #AIinHealthcare #Wearables #LongitudinalData #SleepHealth, #SleepScience sleep.ai Download the transcript here
Transcribe →Rural Hospital Using Secure Texting to Improve Patient Experience with Zach Wood Artera and Meg Jackson Beauregard Health Systems TRANSCRIPT
5d agoTap to summarizeZach Wood, Chief Product and Strategy Officer at Artera, and Meg Jackson, Director of IT for Beauregard Health Systems, join to discuss patient engagement in a rural healthcare setting that previously relied on minimal patient communication, relying on phone calls. The introduction of two-way texting has increased patient engagement, streamlined appointment scheduling, and improved medication adherence. In communities with fewer landlines and limited broadband and computers, this secure texting solution is easy to use and available on patients' mobile devices for convenient access and an effective way to supplement in person care. Zach explains, "Artera works with a very broad set of provider organizations, ranging from specialty clinics to health systems to even federal agencies. We have about a thousand customers that we serve and have organizations like Beauregard that partner with us very closely in rural environments." Meg elaborates, "We may have had some phone calls going out to patients before Artera, but no text reminder. So this was a brand new world for us. We wanted to bring more to the text message, to the patient on their personal devices. We live in a rural area, so maybe broadband is less accessible in our area. So we were trying to bring something to their devices for the patient." "Well, everyone today has a cell phone. Not everyone has a computer. A lot of people don't even have home phones anymore. So we wanted to get that as a text message to the patient, where they could just respond to it. The beauty of Artera, which first drew me to Artera, was the two-way communication. The patient can initiate the conversation without ever having been a patient here before. They can text the main number of our facility and start a conversation, and we can even have different rules set up on the Artera side, where it could trigger a certain conversation based on the patient's keywords. So that really empowers us to make it more customizable for our patient communication." #Artera #BeauregardHealthSystem #DrFirst #EmpoweredPatient #MedicationAdherence #HealthEquity #RuralHealth #HealthcareInnovation #PatientEngagement #DigitalHealth #RuralHealth #PatientExperience #HealthIT #SecureMessaging Artera.io Beauregard.org Listen to the podcast here
Transcribe →Rural Hospital Using Secure Texting to Improve Patient Experience with Zach Wood Artera and Meg Jackson Beauregard Health Systems
5d ago00:19:43Tap to summarizeZach Wood, Chief Product and Strategy Officer at Artera, and Meg Jackson, Director of IT for Beauregard Health Systems, join to discuss patient engagement in a rural healthcare setting that previously relied on minimal patient communication, relying on phone calls. The introduction of two-way texting has increased patient engagement, streamlined appointment scheduling, and improved medication adherence. In communities with fewer landlines and limited broadband and computers, this secure texting solution is easy to use and available on patients' mobile devices for convenient access and an effective way to supplement in person care. Zach explains, "Artera works with a very broad set of provider organizations, ranging from specialty clinics to health systems to even federal agencies. We have about a thousand customers that we serve and have organizations like Beauregard that partner with us very closely in rural environments." Meg elaborates, "We may have had some phone calls going out to patients before Artera, but no text reminder. So this was a brand new world for us. We wanted to bring more to the text message, to the patient on their personal devices. We live in a rural area, so maybe broadband is less accessible in our area. So we were trying to bring something to their devices for the patient." "Well, everyone today has a cell phone. Not everyone has a computer. A lot of people don't even have home phones anymore. So we wanted to get that as a text message to the patient, where they could just respond to it. The beauty of Artera, which first drew me to Artera, was the two-way communication. The patient can initiate the conversation without ever having been a patient here before. They can text the main number of our facility and start a conversation, and we can even have different rules set up on the Artera side, where it could trigger a certain conversation based on the patient's keywords. So that really empowers us to make it more customizable for our patient communication." #Artera #BeauregardHealthSystem #DrFirst #EmpoweredPatient #MedicationAdherence #HealthEquity #RuralHealth #HealthcareInnovation #PatientEngagement #DigitalHealth #RuralHealth #PatientExperience #HealthIT #SecureMessaging Artera.io Beauregard.org Download the transcript here
Transcribe →Rethinking Hospital Operations to Improve Patient Experience Fix Broken Systems with John D'Alesandro Amplefi TRANSCRIPT
5d agoTap to summarizeJohn D'Alesandro, a healthcare operations guru, Amplefi stresses that generally, healthcare operations do not suffer from a lack of staff or technology but from a failure to properly define goals and understand healthcare as a complex system. The reliance on outdated processes and the misapplication of technology has led to the introduction of AI into the environment without first addressing foundational system flaws. He advocates for a simpler, common-sense approach rather than platitudes about patient safety, ensuring that AI models are not trained on inaccurate data from broken systems or undocumented workarounds. John asks, "What is healthcare? Well, healthcare is a ton of things. What is the patient experience? Well, depends on the patient. So when we use these generic terms, they tend to cloud the performance of the system. So I think the first place we need to start is to say something like, " What's an ER experience that we're proud of?" If it's four hours, then it's four hours. But if it's longer or shorter than that, we need targets and reference models to know what we're doing, because we're adding a lot of things and a lot of complexity. We're not really realizing that those are systems. Those systems, when they produce friction, get hit on the frontline. The front lines have to deal with vague, unclear expectations." "Patient experience isn't smiling. It's delivering your care in a reliable way. People get frustrated because they sit around waiting and wondering what the heck's going on. So I think just spending a little bit of time defining everything in your hospital, because every hospital's different." #Amplefi #DigitalHealth #PatientExperience #HealthcareInnovation #ConnectedHealth #PrecisionMedicine #HealthcareOperations #WorkflowDesign#OperationalExcellence #HealthcareSystems #FixTheProcess #BeforeCareBreaks #StructureMatters #ProcessOverTools #StopScalingChaos #HealthcareOperations #HospitalWorkflow #ClinicianBurnout #HealthSystems #AIinHealthcare #Telehealth #CareCoordination amplefi.com Listen to the podcast here
Transcribe →Rethinking Hospital Operations to Improve Patient Experience Fix Broken Systems with John D'Alesandro Amplefi
5d ago00:23:07Tap to summarizeJohn D'Alesandro, a healthcare operations guru, Amplefi stresses that generally, healthcare operations do not suffer from a lack of staff or technology but from a failure to properly define goals and understand healthcare as a complex system. The reliance on outdated processes and the misapplication of technology has led to the introduction of AI into the environment without first addressing foundational system flaws. He advocates for a simpler, common-sense approach rather than platitudes about patient safety, ensuring that AI models are not trained on inaccurate data from broken systems or undocumented workarounds. John asks, "What is healthcare? Well, healthcare is a ton of things. What is the patient experience? Well, depends on the patient. So when we use these generic terms, they tend to cloud the performance of the system. So I think the first place we need to start is to say something like, " What's an ER experience that we're proud of?" If it's four hours, then it's four hours. But if it's longer or shorter than that, we need targets and reference models to know what we're doing, because we're adding a lot of things and a lot of complexity. We're not really realizing that those are systems. Those systems, when they produce friction, get hit on the frontline. The front lines have to deal with vague, unclear expectations." "Patient experience isn't smiling. It's delivering your care in a reliable way. People get frustrated because they sit around waiting and wondering what the heck's going on. So I think just spending a little bit of time defining everything in your hospital, because every hospital's different." #Amplefi #DigitalHealth #PatientExperience #HealthcareInnovation #ConnectedHealth #PrecisionMedicine #HealthcareOperations #WorkflowDesign#OperationalExcellence #HealthcareSystems #FixTheProcess #BeforeCareBreaks #StructureMatters #ProcessOverTools #StopScalingChaos #HealthcareOperations #HospitalWorkflow #ClinicianBurnout #HealthSystems #AIinHealthcare #Telehealth #CareCoordination amplefi.com Download the transcript here
Transcribe →Food Allergy Diagnosis and Treatments Transformed by Microbiome Research and AI Tools with Ilana Golant Food Allergy Fund TRANSCRIPT
6d agoTap to summarizeIlana Golant, Founder and CEO of the Food Allergy Fund, discusses the increasing prevalence and complexity of food allergies in people of all ages and the lack of research, funding, and diagnostics in this field. The Food Allergy Fund is taking a multifaceted approach to address these challenges, including funding microbiome research, exploring drug repurposing, and leveraging AI to develop better diagnostic tools. The goal is to find a cure for food allergies to prevent life-threatening anaphylaxis and drive research into the connection between food allergies and gut and immune health. Ilana explains, "We launched a microbiome research collective recently because we really think the microbiome is the common denominator for many diseases. I mean, food allergy really no longer exists in isolation. It used to be 20 years ago, you would say someone had a peanut allergy. That patient doesn't really exist anymore. It is estimated that 40% of patients who have food allergies also have asthma, which is a significant comorbidity, but their other diseases overlap with Crohn's, juvenile diabetes, and atopic dermatitis, among others." "We really think of food allergy as the canary in the coal mine for lifelong gut and immune health, and what the microbiome dysregulation could mean not only for food allergy, but for broader gut health. And so as part of our Microbiome Collective, we're right now funding studies at six different research institutions across the country to try to figure out what this gut dysbiosis means for food allergy and much more." #FoodAllergyFund #FoodAllergyResearch #FoodAllergyAwareness #Biotech #Immunology #PatientAdvocacy #HealthcareInnovation #FoodAllergy #Microbiome #AIinHealthcare #DrugRepurposing #AllergyResearch #Anaphylaxis #PrecisionMedicine #EmpoweredPatient foodallergyfund.org Listen to the podcast here
Transcribe →Food Allergy Diagnosis and Treatments Transformed by Microbiome Research and AI Tools with Ilana Golant Food Allergy Fund
6d ago00:19:19Tap to summarizeIlana Golant, Founder and CEO of the Food Allergy Fund, discusses the increasing prevalence and complexity of food allergies in people of all ages and the lack of research, funding, and diagnostics in this field. The Food Allergy Fund is taking a multifaceted approach to address these challenges, including funding microbiome research, exploring drug repurposing, and leveraging AI to develop better diagnostic tools. The goal is to find a cure for food allergies to prevent life-threatening anaphylaxis and drive research into the connection between food allergies and gut and immune health. Ilana explains, "We launched a microbiome research collective recently because we really think the microbiome is the common denominator for many diseases. I mean, food allergy really no longer exists in isolation. It used to be 20 years ago, you would say someone had a peanut allergy. That patient doesn't really exist anymore. It is estimated that 40% of patients who have food allergies also have asthma, which is a significant comorbidity, but their other diseases overlap with Crohn's, juvenile diabetes, and atopic dermatitis, among others." "We really think of food allergy as the canary in the coal mine for lifelong gut and immune health, and what the microbiome dysregulation could mean not only for food allergy, but for broader gut health. And so as part of our Microbiome Collective, we're right now funding studies at six different research institutions across the country to try to figure out what this gut dysbiosis means for food allergy and much more." #FoodAllergyFund #FoodAllergyResearch #FoodAllergyAwareness #Biotech #Immunology #PatientAdvocacy #HealthcareInnovation #FoodAllergy #Microbiome #AIinHealthcare #DrugRepurposing #AllergyResearch #Anaphylaxis #PrecisionMedicine #EmpoweredPatient foodallergyfund.org Download the transcript here
Transcribe →Precision Psychiatry Platform Guides Depression Treatment Choices with Talia Cohen Solal NeuroKaire TRANSCRIPT
6d agoTap to summarizeTalia Cohen Solal, CEO and Co-Founder of NeuroKaire, is focused on improving patient outcomes of those with depression by predicting the most effective antidepressant for each individual. The NeuroKaire platform personalizes psychiatric treatment by creating neurons from a patient's blood sample to model their brain and test drug responses, pointing the way to an effective treatment, avoiding prolonged trial-and-error. This is a significant advancement over existing pharmacogenomic tests, which primarily provide information on drug metabolism rather than drug efficacy. This technology is also being applied to other conditions like ADHD, schizophrenia, bipolar disorder, and epilepsy. Talia explains, "At NeuroKaire, we are dedicated to improving patient outcomes in psychiatry and neurology. To do that, we've developed a platform to predict which antidepressant is best for each patient and are expanding out to other disease indications to achieve that mission." "Basically, around 2006, Yamanaka and his colleagues discovered that you could take any cell in the body and turn it back into a stem cell. And that changed everything for the field. So what we can do now is we can take a blood sample, turn it back into a stem cell, and then turn it into whatever cell type we'd like. And our mission is to help people with brain disorders and psychiatric disorders. And so we turn those stem cells into neurons. And now we have a model of the patient's brain. Now we have neurons from the patient's brain and a little ecosystem mimicking a patient's brain. And there we can actually see what's going wrong in the connectivity, what's changed in those patients, and what drugs are going to have the best outcome to reverse those changes." #NeuroKaire #PrecisionPsychiatry #MentalHealth #Antidepressants #BrightKaire #PersonalizedMedicine #PGx #Neuroscience #HealthcareInnovation neurokaire.com Listen to the podcast here
Transcribe →Precision Psychiatry Platform Guides Depression Treatment Choices with Talia Cohen Solal NeuroKaire
6d ago00:18:19Tap to summarizeTalia Cohen Solal, CEO and Co-Founder of NeuroKaire, is focused on improving patient outcomes of those with depression by predicting the most effective antidepressant for each individual. The NeuroKaire platform personalizes psychiatric treatment by creating neurons from a patient's blood sample to model their brain and test drug responses, pointing the way to an effective treatment, avoiding prolonged trial-and-error. This is a significant advancement over existing pharmacogenomic tests, which primarily provide information on drug metabolism rather than drug efficacy. This technology is also being applied to other conditions like ADHD, schizophrenia, bipolar disorder, and epilepsy. Talia explains, "At NeuroKaire, we are dedicated to improving patient outcomes in psychiatry and neurology. To do that, we've developed a platform to predict which antidepressant is best for each patient and are expanding out to other disease indications to achieve that mission." "Basically, around 2006, Yamanaka and his colleagues discovered that you could take any cell in the body and turn it back into a stem cell. And that changed everything for the field. So what we can do now is we can take a blood sample, turn it back into a stem cell, and then turn it into whatever cell type we'd like. And our mission is to help people with brain disorders and psychiatric disorders. And so we turn those stem cells into neurons. And now we have a model of the patient's brain. Now we have neurons from the patient's brain and a little ecosystem mimicking a patient's brain. And there we can actually see what's going wrong in the connectivity, what's changed in those patients, and what drugs are going to have the best outcome to reverse those changes." #NeuroKaire #PrecisionPsychiatry #MentalHealth #Antidepressants #BrightKaire #PersonalizedMedicine #PGx #Neuroscience #HealthcareInnovation neurokaire.com Download the transcript here
Transcribe →